Skip to main content
. 2014 Aug 23;11:43. doi: 10.1186/s12970-014-0043-x

Figure 1.

Figure 1

Baseline subtracted serum testosterone levels in placebo- and Resettin®/MyTosterone™-treated participants. Shown are the total serum testosterone levels from participants after 3, 7 and 14 days of 800 mg/day placebo (a) or Resettin®/MyTosterone™, or 1200 mg/day placebo or Resettin®/MyTosterone™ (b) as determined by ELISA. Each experimental group had between 9 and 10 participants, and results are indicative of one trial. Error bars denote standard deviation of the experimental mean.